STUNS Life science

🌟 Congratulations Uppsala County! 🌟 Uppsala leads Sweden in life science employment growth and sees an impressive average of 10 new life science companies founded annually! 🚀 #lifescience #innovation

🔔 Last chance to participate in the Life Science Barometer 2025! 🔔   Are you part of a life science company? Don’t miss the opportunity to contribute to one of the most important surveys highlighting the needs and trends in the swedish life science industry. We request one answer per company, from a strategic leader (CEO’s or similar) of any company or organization within life sciences.   💡Why is your input important? Your insights will help strengthen and shape the Swedish life science sector by providing valuable data for informed decision-making and international benchmarking.   ⏰The survey only takes 10 minutes to complete. Over 100 companies have already responded – has yours?   Complete the survey here: https://lnkd.in/dAgF7DY5

Det här är vad vi kallar ett 40-års jubileum!🥳 I fredags firade vi den starka samverkanskulturen i Uppsala där vi, istället för att fokusera på det som varit, riktade blickarna framåt mot den framtid och det Uppsala vi vill skapa. Vi vill rikta ett STORT tack till alla som deltog under fredagens workshop och under kvällens firande på Uppsala slott – ni gjorde dagen till en succé och ett avstamp för allt vi kan åstadkomma tillsammans🙌🌟 Nu fortsätter vi att blicka framåt. Med full kraft tillsammans når vi nya höjder! 🚀 Tack till kvällens talare – Andreas Larsson, Björn Arvidsson, Stefan Attefall, Charlotte Platzer Björkman, Anders Wall och Evelina Vågesjö – samt Phosworks, Bjerking, Mötesplats Studenternas, Advokatfirman Lindahl, UIC - Uppsala Innovation Centre och Uppsala kommun för möjligheten att nyttja era fina lokaler.🙏 Ett sista tack riktas till STUNS stiftare – Länsstyrelsen Uppsala Län, Stockholms Handelskammare, Uppsala kommun, Uppsala universitet, SLU - Sveriges lantbruksuniversitet och Region Uppsala.

Did you know that the Stockholm-Uppsala life science cluster, #capitaloflife, is ranked as the sixth-best in Europe? 🏅 Being part of a strong #community like ours opens up incredible opportunities and synergy effects. To share our story and increase the cluster's attractiveness, we rely on accurate data and statistics. This not only helps us make smart, strategic decisions but also strengthens our story and enhances the cluster’s attractiveness. 💡Want to use this valuable data too? With Insight Machine, you can access the insights you need to make informed decisions and discover new opportunities in the life science sector. Discover the latest statistics and read the newly published issue of Insight magazine: https://lnkd.in/dPwcJbgK

📣 𝗧𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗕𝗮𝗿𝗼𝗺𝗲𝘁𝗲𝗿 𝘀𝘂𝗿𝘃𝗲𝘆 𝗶𝘀 𝗻𝗼𝘄 𝗼𝗽𝗲𝗻! In just 10 minutes, you can help create a valuable data-driven snapshot of the Swedish life science industry. 💡 𝗪𝗵𝗼 𝘀𝗵𝗼𝘂𝗹𝗱 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗲? Senior management from companies and organizations within the life science sector, as well as those supporting the industry, such as service providers and investors. 💡 𝗪𝗵𝘆 𝗶𝘀 𝘆𝗼𝘂𝗿 𝗶𝗻𝗽𝘂𝘁 𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁? Your participation helps promote and strengthen the Swedish life science industry by providing critical data for informed decisions and international benchmarking. Last year, 200 companies took part in the survey. We hope more will join this year in this unique effort to gather essential insights and help our industry thrive 🪴📈 🔗 For more information: https://lnkd.in/dAgF7DY5 🔗 Direct link to survey: https://lnkd.in/dKi8Pc6T Produced by SwedenBIO in partnership with Medicon Village, Sahlgrenska Science Park, Stockholm Science City, Citeline and STUNS Life science

📍Reporting from Malmö at the Nordic Life Science Days! We're excited to be at NLSDays with the BRIDGE Sweden project, exploring collaborations to advance biological product development and strengthen Swedish life science. Meet Fanny Blom and Malin Wiederholm at booth C13 together with project partners Testa Center, Lund Stem Cell Center and pre-GMP Facility at Lunds universitet and SciLifeLab Drug Discovery & Development. #NLSDays

How can small and growing companies in the life science sector work with sustainability?🌍 On September 24th, you have the chance to gain valuable insights at Stockholm Science City's breakfast seminar. You’ll meet Urban Adolfsson, CFO at Gradientech as well as STUNS very own Fanny Blom - who will share her top tips on how to implement sustainability in a way that suits your business. There are still spots available – Register now!

Thank you to everyone who participated in yesterday’s kick-off and investment meeting at Bjerking! 🙌   Special thanks to the BIO-X winners – ArgusEye, Rarity Bioscience , Readily Diagnostics , Phenaros Pharmaceuticals , Strike Pharma AB – and the BIO-X runner ups – Cellda AB, Stardots, Extem Pharma, Oxlantic Medical – who truly impressed us with their pitches. We are excited to follow your journey in the BIO-X Accelerate program and look forward to the progress you’ll make in the Life-Science industry.🚀   We would also like to extend our gratitude to our partner Connect Sverige Region Uppsala for your support!

A new round of BIO-X Accelerate is now commencing. We are pleased to welcome five selected companies: ArgusEye, Phenaros Pharmaceuticals, Rarity Bioscience , Readily Diagnostics, and Strike Pharma AB. Last in line to presented is the company Readily Diagnostics. Readily Diagnostics' technology is based on padlock probes and rolling circle amplification (RCA), combined with a proprietary solution to enhance speed. It integrates a molecular method with microfluidics, allowing for use in various settings or with standard laboratory equipment for high throughput. This technology offers the robustness and specificity of RT-PCR without requiring specialized instruments. "We are incredibly excited and honored to have been selected for the BIO-X Accelerate program! We see this as validation that our diagnostic tests will make a significant difference in healthcare. With the support of BIO-X Accelerate, we can now take further steps to develop our clinical test, advance our regulatory journey towards CE-IVD certification, and offer it to healthcare providers more quickly." — Liza Löf (Mokvist), PhD, CEO. Are you an investor looking for new and exciting Life Science companies? Sign up for the BIO-X Accelerate Kickoff and Investment Meeting to meet Readily Diagnostics and nine other pitching companies. Register here: https://lnkd.in/diurc_gd Funding is available through European Regional Development Fund (ERDF) administered by The Swedish Agency for Economic and Regional Growth (Tillväxtverket).

A new round of BIO-X Accelerate is now commencing. We are pleased to welcome five selected companies: ArgusEye, Phenaros Pharmaceuticals, Rarity Bioscience , Readily Diagnostics, and Strike Pharma AB. Next in line is the company Phenaros Pharmaceuticals. Phenaros Pharmaceuticals use AI and automation to accelerate drug discovery. They employ state-of-the-art AI to guide decisions, along with robotics and automation for intelligent experimentation. As a data-centric company, Phenaros Pharmaceuticals systematically engineers the data used to build their AI system, enabling them to perform the right experiments at the right time, while reducing costs and time in drug discovery cycles. "BIO-X Accelerate offers substantial value for us by providing funding and strategic support to validate and scale our drug discovery platform. This initiative allows us to solidify our technology by partnering with leading pharmaceutical companies and enhances our ability to contribute to bringing effective drugs to market faster." — Jordi Carreras Puigvert, CSO. Are you an investor looking for new and exciting Life Science companies? Sign up for the BIO-X Accelerate Kickoff and Investment Meeting to meet Phenaros Pharmaceuticals and nine other pitching companies. Register here: https://lnkd.in/diurc_gd Funding is available through European Regional Development Fund (ERDF) administered by The Swedish Agency for Economic and Regional Growth (Tillväxtverket).